Membrane-targeted antibiotic for the treatment of skin and lung infections caused by drug resistant pathogens including MRSA, VISA, VRE and S pneumoniae (2011–2015)

Grant type:
Wellcome Trust Seeding Drug Discovery
Researchers:
  • NHMRC Leadership Fellow
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Director, UQ Centre for Clinical Re
    Faculty of Medicine
    Centre Director of UQ Centre for Cl
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
The Wellcome Trust